# Sativus Tech Corp.

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/Sativus Tech Corp.).

## Overview

SATIVUS TECH CORP. is a Delaware-based company focused through its Israeli subsidiary Saffron Tech on developing automated indoor agriculture systems for saffron cultivation. Its business centers on proprietary vertical-farming and remote-management technology designed to grow saffron and related exotic crops in controlled environments.

## Products & services

• Automated indoor saffron cultivation systems
• Vertical farming and controlled-environment growing
• Remote-managed turnkey growing containers
• Agricultural R&D for exotic plants and mushrooms
• Saffron bulbs, corms, and cultivation pilots

- **Controlled-environment agriculture systems** (60%) — Automated growing containers and indoor cultivation systems for saffron and other crops.
- **Agricultural R&D and prototyping** (25%) — Research, testing, and proof-of-concept development for proprietary cultivation methods.
- **Saffron cultivation operations** (15%) — Pilot and pre-commercial saffron growing activities using vertical farming technology.

- Automated indoor saffron cultivation systems
- Vertical farming and controlled-environment growing
- Remote-managed turnkey growing containers
- Agricultural R&D for exotic plants and mushrooms
- Saffron bulbs, corms, and cultivation pilots

## Customers

The company’s end users are buyers of saffron and saffron-derived products in food, beauty, wellness, and pharmaceutical applications. Its technology is also relevant to growers or partners seeking turnkey controlled-environment agriculture solutions for high-value crops.

- **Food service and specialty food buyers** (primary) — Buy saffron for premium culinary use where consistency, quality, and supply matter.
- **Beauty and wellness companies** (secondary) — Buy saffron or saffron-derived inputs for natural cosmetics and wellness products.
- **Pharmaceutical and supplement users** (secondary) — Buy saffron for formulations tied to anti-oxidant, anti-depressant, and antiseptic claims.
- **Agricultural partners and pilot customers** (emerging) — Evaluate or adopt the company’s automated growing systems and cultivation protocols.

- Food industry buyers using saffron as a premium ingredient
- Chefs and restaurants seeking consistent high-quality saffron
- Beauty and wellness brands using saffron extracts
- Pharmaceutical and supplement applications for saffron compounds
- Potential agricultural partners for controlled-environment systems

## Geography

The company is incorporated in Delaware and operates through Saffron Tech in Israel, where its cultivation pilots and R&D activities are based. Its commercial and technical focus is tied to Israeli agricultural research and controlled-environment growing sites, including the Golan Heights and Ganei Tal.

- **Israel** (100%) — Operations, pilots, and R&D are centered in Israel

- Incorporated in Delaware, United States
- Core operations and R&D are based in Israel
- Pilot cultivation sites include the Golan Heights
- Ganei Tal pilot site supports commercial-like testing
- Geography matters because cultivation is site-specific and climate-controlled

## Strategy

Sativus Tech’s strategy is to commercialize a proprietary, fully automated saffron-growing platform that can produce multiple cultivation cycles per year in controlled indoor environments. It is also building proof-of-concept sites and testing protocols to support future scale-up and broader use cases in exotic crops.

- **Commercialize the saffron cultivation platform** (short-term) — A repeatable production system is needed to convert R&D into revenue-generating operations.
- **Scale controlled-environment production** (medium-term) — Higher-cycle indoor cultivation is intended to improve output and support larger customers.
- **Secure external financing** (short-term) — Development-stage ag-tech businesses require capital before operations become self-funding.

- Advance proprietary vertical-farming saffron technology
- Move from pilot sites toward commercial-scale deployment
- Use R&D to improve yield, consistency, and scalability
- Target high-value end markets for saffron demand
- Seek financing to support development and execution

## Risks

The company faces substantial execution and financing risk because its business is still in development and depends on successful commercialization of a new cultivation platform. It also carries typical ag-tech risks around crop performance, technology reliability, scaling, and customer adoption, while its Israeli operating base adds site and regional exposure.

- **Financing shortfall** [critical] — The company states it needs additional capital to continue operations and fund its business plan.
- **Going concern uncertainty** [critical] — Auditors included a going-concern explanatory paragraph due to uncertainty over future funding and profitability.
- **Commercial scale-up risk** [high] — Pilot and proof-of-concept systems may not translate into reliable large-scale production.
- **Dilution from future financings** [high] — Management notes future equity or convertible financing may be dilutive and costly.
- **Agricultural and operational variability** [medium] — Crop outcomes depend on controlled-environment performance, biological inputs, and site execution.

- Going-concern risk if additional financing is not obtained
- Commercialization risk if pilot results do not scale
- Technology risk from automated growing system performance
- Agricultural risk from crop yields, pests, and cultivation cycles
- Dilution risk from future equity or convertible financing

## Accounting

The most important accounting issue is going-concern assessment, because the company’s financial statements depend on continued access to financing and future profitable operations. Investors should also watch convertible loans, warrants, and related fair-value revaluations, which can create non-cash gains or losses and affect reported results.

- **Going concern** — May affect asset valuation, liability classification, and investor perception
- **Convertible loans and warrants** — Can materially distort period-to-period earnings and cash flow interpretation
- **Research and development expense** — Directly affects operating loss and reflects development intensity
- **Consolidation and non-controlling interest** — Impacts reported control, equity attribution, and minority interest

- Going-concern assessment drives asset and liability presentation
- Convertible loans and warrants create fair-value volatility
- Related-party funding affects financing and liquidity disclosures
- R&D spending is a key operating expense for the business model
- Minority interest in Saffron Tech affects consolidation economics

---

*Last updated: 2026-04-29T04:54:34.136213+00:00*